Novo Nordisk and Eli Lilly can both gain GLP-1 market share this year, says Citi's Meacham
286 View
- Publish Date:
- 9 January, 2026
- Category:
- CNBC
- Video License
- Standard License
- Imported From:
- Youtube
Geoff Meacham, Citi analyst, joins 'Fast Money' to talk what the year ahead holds for competition in the obesity drug market.
By: CNBC Television
Title: Novo Nordisk and Eli Lilly can both gain GLP-1 market share this year, says Citi's Meacham
Sourced From: www.youtube.com/watch?v=CrZ4bt8BrKg
News.... browse around here
F1!!
Hot wife Lawrence Stroll
Trading News: https://www.bitcoinisle.com/2022/03/01/2-key-derivatives-metrics-signal-bitcoin-traders-expect-btc-to-hold-40000/
Exciting Finds: Zet news roundup
Stay up to date on China: https://www.chinapulse.com/data-news/2021/02/23/researchers-say-china-used-the-nsas-epme-exploit-to-attack-windows-machines-for-years-before-shadow-brokers-leaked-the-agencys-zero-day-toolkit-online-andy-greenberg-wired/
Output QR Code
Did you miss our previous article...
https://newshub247.com/cnbc/jobs-report-doesnt-motivate-the-fed-to-move-at-end-of-month-says-fmr-dallas-fed-president-fischer
